JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.02B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$3.55B |
| 3 |
Eli Lilly
LLY
|
+$2.61B |
| 4 |
Amphenol
APH
|
+$2.33B |
| 5 |
TotalEnergies
TTE
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.67B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$7.48B |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.25B |
| 4 |
NVIDIA
NVDA
|
+$6.05B |
| 5 |
Microsoft
MSFT
|
+$5.54B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Miscellaneous | 24.97% |
| 3 | Financials | 9.75% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Healthcare | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5726
Falcon's Beyond
FBYD
$413M
| $88.2K | ﹤0.01% |
+5,877
| New | +$81.3K |
2025 Q4
0 quarters
|
|
5727
WisdomTree Emerging Markets Local Debt Fund
ELD
$135M
| $88.2K | ﹤0.01% |
3,020
-840
| -22% | -$24.2K |
2023 Q3
9 quarters
|
|
5728
CALL
Range Resources
RRC
$8.79B
| $88.2K | ﹤0.01% |
+2,500
| New | +$93.1K |
2025 Q4
0 quarters
|
|
5729
Usana Health Sciences
USNA
$266M
| $88.1K | ﹤0.01% |
4,489
-4,915
| -52% | -$102K |
2013 Q2
50 quarters
|
|
|
PINE
5730
Alpine Income Property Trust
PINE
$311M
| $88.1K | ﹤0.01% |
5,267
-9,129
| -63% | -$143K |
2021 Q4
16 quarters
|
|
5731
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.33B
| $87.9K | ﹤0.01% |
2,386
-18,685
| -89% | -$688K |
2018 Q3
29 quarters
|
|
5732
Opus Small Cap Value ETF
OSCV
$623M
| $87.9K | ﹤0.01% |
2,374
-122
| -5% | -$4.57K |
2022 Q4
12 quarters
|
|
|
SUPV
5733
Grupo Supervielle
SUPV
$597M
| $87.6K | ﹤0.01% |
+7,413
| New | +$72.5K |
2025 Q4
0 quarters
|
|
5734
CALL
ProShares UltraShort Health Care
RXD
$3.21M
| $87.3K | ﹤0.01% |
1,250
-13,500
| -92% | -$265K |
2025 Q2
2 quarters
|
|
5735
Rezolute
RZLT
$394M
| $87.2K | ﹤0.01% |
36,948
+3,747
| +11% | +$29.4K |
2025 Q2
2 quarters
|
|
5736
Kaltura
KLTR
$195M
| $87.1K | ﹤0.01% |
53,083
-41,620
| -44% | -$65.7K |
2022 Q4
12 quarters
|
|
|
STRZ
5737
Starz Entertainment Corp
STRZ
$391M
| $87K | ﹤0.01% |
7,437
-4,781
| -39% | -$54.8K |
2025 Q2
2 quarters
|
|
|
ACH
5738
Accendra Health
ACH
$42.9M
| $87K | ﹤0.01% |
31,076
-3,682
| -11% | -$13.2K |
2013 Q2
50 quarters
|
|
5739
State Street Multi-Asset Real Return ETF
RLY
$1.38B
| $86.9K | ﹤0.01% |
2,762
+2,224
| +413% | +$69.8K |
2025 Q3
1 quarter
|
|
5740
PUT
SolarEdge
SEDG
$1.9B
| $86.5K | ﹤0.01% |
3,000
| – | – |
2024 Q3
5 quarters
|
|
5741
iShares MSCI Netherlands ETF
EWN
$696M
| $86.5K | ﹤0.01% |
1,516
| – | – |
2021 Q2
18 quarters
|
|
5742
BK Technologies
BKTI
$283M
| $86.5K | ﹤0.01% |
1,159
-10,444
| -90% | -$748K |
2023 Q3
9 quarters
|
|
|
ATYR
5743
aTyr Pharma
ATYR
$28.8M
| $86.4K | ﹤0.01% |
110,373
+4,556
| +4% | +$3.74K |
2025 Q2
2 quarters
|
|
5744
T. Rowe Price QM US Bond ETF
TAGG
$2.6B
| $86.1K | ﹤0.01% |
2,000
-905
| -31% | -$39.1K |
2025 Q2
2 quarters
|
|
5745
Franklin Financial Services
FRAF
$280M
| $86K | ﹤0.01% |
1,713
-9,036
| -84% | -$444K |
2025 Q1
3 quarters
|
|
5746
USCB Financial Holdings
USCB
$408M
| $86K | ﹤0.01% |
4,668
-201
| -4% | -$3.59K |
2021 Q4
16 quarters
|
|
|
CBNA
5747
Chain Bridge Bancorp
CBNA
$308M
| $84.9K | ﹤0.01% |
2,452
-1,042
| -30% | -$33.7K |
2025 Q2
2 quarters
|
|
5748
BV Financial
BVFL
$180M
| $84.9K | ﹤0.01% |
4,680
-3,455
| -42% | -$59.5K |
2025 Q2
2 quarters
|
|
5749
TriSalus Life Sciences
TLSI
$256M
| $84.8K | ﹤0.01% |
12,150
+4,629
| +62% | +$25.9K |
2024 Q1
7 quarters
|
|
5750
Quantum-Si Incorporated
QSI
$313M
| $84.6K | ﹤0.01% |
76,909
+13,629
| +22% | +$22.2K |
2021 Q4
16 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2025 Portfolio in Review
As of Q4 2025, JP Morgan Chase held 7,944 positions worth $1.59T, down 4.6% from $1.67T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
JP Morgan Chase withdrew a net $106B in Q4 2025, closing 563 positions and reducing 3,329 holdings. Its most notable exit was Interpublic Group of Companies, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, JP Morgan Chase opened a new position in Quadratic Interest Rate Volatility and Inflation Hedge ETF worth $99.9M.
- JP Morgan Chase's largest Q4 2025 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 5,216,227 shares worth $99.9M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2025, an estimated $4.02B increase.
- JP Morgan Chase's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $9.67B.
- JP Morgan Chase fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $228M.
- JP Morgan Chase's ten largest holdings make up 26% of its $1.59T portfolio in Q4 2025.
- JP Morgan Chase opened 577 new positions and closed 563 in Q4 2025.
- JP Morgan Chase's portfolio value fell 4.6% quarter-over-quarter to $1.59T.
Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.